Aslam, M.S.; Zaidi, S.Z.J.; Toor, R.H.; Gull, I.; Iqbal, M.M.; Abbas, Z.; Tipu, I.; Ahmed, A.; Athar, M.A.; Harito, C.;
et al. Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect. Materials 2021, 14, 3318.
https://doi.org/10.3390/ma14123318
AMA Style
Aslam MS, Zaidi SZJ, Toor RH, Gull I, Iqbal MM, Abbas Z, Tipu I, Ahmed A, Athar MA, Harito C,
et al. Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect. Materials. 2021; 14(12):3318.
https://doi.org/10.3390/ma14123318
Chicago/Turabian Style
Aslam, Muhammad Shahbaz, Syed Zohaib Javaid Zaidi, Rabail Hassan Toor, Iram Gull, Muhammad Mudassir Iqbal, Zaigham Abbas, Imran Tipu, Aftab Ahmed, Muhammad Amin Athar, Christian Harito,
and et al. 2021. "Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect" Materials 14, no. 12: 3318.
https://doi.org/10.3390/ma14123318
APA Style
Aslam, M. S., Zaidi, S. Z. J., Toor, R. H., Gull, I., Iqbal, M. M., Abbas, Z., Tipu, I., Ahmed, A., Athar, M. A., Harito, C., & Hassan, S.-u.
(2021). Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect. Materials, 14(12), 3318.
https://doi.org/10.3390/ma14123318
